用于治疗肝癌的乌尔索西胆酸:一项前后试点研究
Ethan Weinberg1, Aimee Stonelake1, Kelly Borges1
1Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, USA.
Clinical and experimental hepatology
|December 19, 2024
概括
乌尔索多西胆酸 (UDCA) 显示出在治疗肝脏沙尔科毒症方面的潜力,并观察到肝脏酶的降低. 需要进一步的多中心研究来证实UDCA的存在.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- Sarcoidosis 是一种多系统性炎症性疾病,其特征是非病变性颗粒瘤.
- 肝脏参与沙尔科发症可能导致肝脏功能障碍.
- 缺少针对肝脏沙科毒症的 Ursodeoxycholic 酸 (UDCA) 的前性研究.
研究的目的:
- 为了评估乌尔索多西胆酸 (UDCA) 对肝脏沙丘症患者的影响.
- 评估UDCA作为类瘤中肝脏参与的潜在治疗方法的有效性.
主要方法:
- 采用了一个单中心,开放标签,前性,前后研究设计.
- 招募了7名患有肝硬性沙丘病的患者.
- 患者接受了6个月的观察期,随后接受了6个月的UDCA治疗.
主要成果:
- 在UDCA治疗后观察到性酸酶 (ALP) 和-胺转移酶 (GGT) 的降低,尽管在统计学上没有显著意义.
- 关键的二次终点,包括ALT,AST和肝硬度 (VCTE),也显示下降,但没有达到统计学意义.
- 一名患者因恶心而停止服用UDCA;另一个患者由于与食道癌无关而退出.
结论:
- 乌尔索多西胆酸 (UDCA) 显示出作为肝脏沙尔科毒症的第一线治疗的潜力.
- 更大的,多中心,有更长时间的前性研究是必要的,以验证这些发现,并确定UDCA在治疗肝硬化症中的作用.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:


